Detalles de la búsqueda
1.
Quantitative PCR Is Faster, More Objective, and More Reliable Than Immunohistochemistry for the Diagnosis of Cytomegalovirus Gastrointestinal Disease in Allogeneic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(11): 2281-2286, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31325586
2.
Single Antigen-Mismatched Unrelated Hematopoietic Stem Cell Transplantation Using High-Dose Post-Transplantation Cyclophosphamide Is a Suitable Alternative for Patients Lacking HLA-Matched Donors.
Biol Blood Marrow Transplant
; 24(6): 1196-1202, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29410343
3.
Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention after Allogeneic Hematopoietic Cell Transplantation from HLA-Matched Donors Has More Advantages Than Limitations.
Transplant Cell Ther
; 30(2): 213.e1-213.e12, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38042256
4.
Effects of CYP3A5 Genotype on Tacrolimus Pharmacokinetics and Graft-versus-Host Disease Incidence in Allogeneic Hematopoietic Stem Cell Transplantation.
Pharmaceuticals (Basel)
; 17(5)2024 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38794124
5.
Effect of CD34+ Cell Dose on the Outcomes of Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide.
Transplant Cell Ther
; 29(3): 181.e1-181.e10, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36526259
6.
Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide.
Pharmaceuticals (Basel)
; 15(12)2022 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36558980
7.
Bacterial Bloodstream Infections in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide.
Transplant Cell Ther
; 28(12): 850.e1-850.e10, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36089250
8.
PTCY and Tacrolimus for GVHD Prevention for Older Adults Undergoing HLA-Matched Sibling and Unrelated Donor AlloHCT.
Transplant Cell Ther
; 28(8): 489.e1-489.e9, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35577323
9.
High-Dose Cyclophosphamide and Tacrolimus as Graft-versus-Host Disease Prophylaxis for Matched and Mismatched Unrelated Donor Transplantation.
Transplant Cell Ther
; 27(7): 619.e1-619.e8, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33895157
10.
Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis.
Bone Marrow Transplant
; 55(7): 1264-1271, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32103146
11.
A reproducible and safe at-home allogeneic haematopoietic cell transplant program: first experience in Central and Southern Europe.
Bone Marrow Transplant
; 55(5): 965-973, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31932656
12.
Improving security of autologous hematopoietic stem cell transplant in patients with light-chain amyloidosis.
Bone Marrow Transplant
; 54(8): 1295-1303, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30664727
Resultados
1 -
12
de 12
1
Próxima >
>>